Inspire

This is the limited version of the Inspire company profile: Join LinkedIn or Sign In to see more information.

Inspire is engaged primarily in the development of drugs for ophthalamic and respiratory indications. At the present time, the company is leveraging its expertise in the area of P2Y agonists to advance treatments for cystic fibrosis and dry eye disease to the clinic. In addition to the R&D focus, Inspire also has several marketed products (Elestat, AzaSite) that are marketed by an in-house sales force.

Your Connections to Inspire

To see how you’re connected: Join Now or Sign In

Popular Profiles at Inspire

New Hires and Recent Promotions at Inspire

  • Mary Ellis Bogden, Associate Director, CMC Operations

    was Sr. Manager, CMC Operations - 4 months ago

  • Heather Deal, Clinical Research Associate

    was Clincal Research Coordinator - 2 months ago

  • Rozemarijn Verhoeven, Manager, Scientific Affairs

    was Associate Manager, Toxicology - 4 months ago

  • Shannon Franks, Quality & Compliance Associate

    was Senior Executive Assistant, Sales - 4 months ago

To see more new hires & promotions: Join Now or Sign In

Last edited by Principal Scientist at Inspire Pharmaceuticals

In partnership with BusinessWeek

Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.

This LinkedIn Company Profile was created by LinkedIn and is about Inspire. This page is not endorsed by or affiliated with Inspire. For questions regarding LinkedIn Company Profiles, contact us.

Inspire (ISPH) full company profile, stock quotes, financial statements and more.

Interactive Data Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions